The Next Generation of Cardiovascular Drugs
Feb 14, 10:40 PM
The cardiometabolic space is more than just the obesity revolution. The Tema HRTS ETF portfolio manager, David K. Song, MD, PhD, CFA, outlines the trends he expects for 2024 and beyond.